Does SECUKINUMAB Cause Coronary artery disease? 115 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 115 reports of Coronary artery disease have been filed in association with SECUKINUMAB (COSENTYX). This represents 0.1% of all adverse event reports for SECUKINUMAB.
115
Reports of Coronary artery disease with SECUKINUMAB
0.1%
of all SECUKINUMAB reports
8
Deaths
82
Hospitalizations
How Dangerous Is Coronary artery disease From SECUKINUMAB?
Of the 115 reports, 8 (7.0%) resulted in death, 82 (71.3%) required hospitalization, and 20 (17.4%) were considered life-threatening.
Is Coronary artery disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 115 reports have been filed with the FAERS database.
What Other Side Effects Does SECUKINUMAB Cause?
Drug ineffective (27,434)
Psoriasis (21,976)
Pain (15,244)
Arthralgia (13,769)
Fatigue (9,406)
Psoriatic arthropathy (8,900)
Pruritus (8,755)
Malaise (8,570)
Rash (8,023)
Condition aggravated (7,536)
What Other Drugs Cause Coronary artery disease?
ROSIGLITAZONE (4,982)
ASPIRIN (807)
METFORMIN\ROSIGLITAZONE (738)
AVANDIA (667)
ROSUVASTATIN (508)
TESTOSTERONE (453)
PANTOPRAZOLE (422)
CLOPIDOGREL BISULFATE (402)
ALBUTEROL (391)
ADALIMUMAB (353)
Which SECUKINUMAB Alternatives Have Lower Coronary artery disease Risk?
SECUKINUMAB vs SELADELPAR LYSINE
SECUKINUMAB vs SELEGILINE
SECUKINUMAB vs SELENIUM
SECUKINUMAB vs SELENIUM SULFIDE
SECUKINUMAB vs SELEXIPAG